Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

ATM splicing defect

Individuals with mutations in the ATM gene develop ataxia-telangiectasia, a neurodegenrative disorder characterized by immunological defects and cancer predisposition. In an Advanced Online Publication from Nature Genetics, Pagani et al. describe a new kind of ATM mutation that leads to an unusual splicing defect (11 March 2002, DOI:10.1038/ng858). The mutant ATM allele contains a four-nucleotide deletion (GTAA) within intron 20. This deletion results in the inclusion of a 65 nucleotide 'cryptic exon' in the ATM mRNA. The ATM sequence, termed intron-splicing processing element (ISPE), is complementary to U1 snRNA. Experiments with a hybrid minigene confirmed the importance of the ISPE sequence; and interaction with U1 snRNA affected the efficiency of intron removal. Introduction of the ISPE sequence into a different genomic context, exon 9 of the cystic fibrosis transmembrane regulator (CFTR) gene, caused exon skipping and splicing defects.

References

  1. 1.

    The genetic defect in ataxia-telangiectasia.

  2. 2.

    Nature Genetics, [http://www.nature.com/ng/]

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weitzman, J.B. ATM splicing defect. Genome Biol 3, spotlight-20020314-01 (2002). https://doi.org/10.1186/gb-spotlight-20020314-01

Download citation

Keywords

  • Cystic Fibrosis
  • Online Publication
  • Genomic Context
  • Cancer Predisposition
  • Cystic Fibrosis Transmembrane Regulator